Pohlreichova V - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2009	1
2012	1
2013	1
2020	1
2025	0

Page 1

Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort.

Salaj P, Geierová V, Ivanová E, Loužil J, Pohlreichová V, Hrachovinová I, Dulíček P. Salaj P, et al. Among authors: pohlreichova v. Haemophilia. 2020 Jul;26(4):643-651. doi: 10.1111/hae.14084. Epub 2020 Jun 26. Haemophilia. 2020. PMID: 32590889

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study.

Saleh MN, Bussel JB, Cheng G, Meyer O, Bailey CK, Arning M, Brainsky A; EXTEND Study Group. Saleh MN, et al. Blood. 2013 Jan 17;121(3):537-45. doi: 10.1182/blood-2012-04-425512. Epub 2012 Nov 20. Blood. 2013. PMID: 23169778 Free article. Clinical Trial.

Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic.

Salaj P, Brabec P, Penka M, Pohlreichova V, Smejkal P, Cetkovsky P, Dusek L, Hedner U. Salaj P, et al. Among authors: pohlreichova v. Haemophilia. 2009 May;15(3):752-9. doi: 10.1111/j.1365-2516.2009.02007.x. Haemophilia. 2009. PMID: 19432926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year